This is a preview of subscription content, log in via an institution to check access.
References
Aviello, G., and Knaus, U.G. (2017). ROS in gastrointestinal inflammation: rescue or sabotage? Br J Pharmacol 174, 1704–1718.
Dandona, P., Thusu, K., Cook, S., Snyder, B., Makowski, J., Armstrong, D., and Nicotera, T. (1996). Oxidative damage to DNA in diabetes mellitus. Lancet 347, 444–445.
Fan, K., Xi, J., Fan, L., Wang, P., Zhu, C., Tang, Y., Xu, X., Liang, M., Jiang, B., Yan, X., et al. (2018). In vivo guiding nitrogen-doped carbon nanozyme for tumor catalytic therapy. Nat Commun 9, 1440.
Huang, Y., Ren, J., and Qu, X. (2019). Nanozymes: classification, catalytic mechanisms, activity regulation, and applications. Chem Rev 119, 4357–4412.
Kwon, H.J., Kim, D., Seo, K., Kim, Y.G., Han, S.I., Kang, T., Soh, M., and Hyeon, T. (2018). Ceria nanoparticle systems for selective scavenging of mitochondrial, intracellular, and extracellular reactive oxygen species in Parkinson’s disease. Angew Chem Int Ed 57, 9408–9412.
Liang, M., and Yan, X. (2019). Nanozymes: from new concepts, mechanisms, and standards to applications. Acc Chem Res 52, 2190–2200.
Liu, Y., Cheng, Y., Zhang, H., Zhou, M., Yu, Y., Lin, S., Jiang, B., Zhao, X., Miao, L., Wei, C.W., et al. (2020). Integrated cascade nanozyme catalyzes in vivo ROS scavenging for anti-inflammatory therapy. Sci Adv 6, eabb2695.
Pardi, D.S., Tremaine, W.J., Sandborn, W.J., and McCarthy, J.T. (1998). Renal and urologic complications of inflammatory bowel disease. Am J Gastroenterol 93, 504–514.
Wei, H., and Wang, E. (2013). Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes. Chem Soc Rev 42, 6060.
Wu, J., Wang, X., Wang, Q., Lou, Z., Li, S., Zhu, Y., Qin, L., and Wei, H. (2019). Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II). Chem Soc Rev 48, 1004–1076.
Wu, J., Yu, Y., Cheng, Y., Cheng, C., Zhang, Y., Jiang, B., Zhao, X., Miao, L., and Wei, H. (2021). Ligand-dependent activity engineering of glutathione peroxidase-mimicking MIL-47(V) metal-organic framework nanozyme for therapy. Angew Chem Int Ed 60, 1227–1234.
Zhang, S., Ermann, J., Succi, M.D., Zhou, A., Hamilton, M.J., Cao, B., Korzenik, J.R., Glickman, J.N., Vemula, P.K., Glimcher, L.H., et al. (2015). An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease. Sci Transl Med 7, 300ra128.
Zhao, J., Cai, X., Gao, W., Zhang, L., Zou, D., Zheng, Y., Li, Z., and Chen, H. (2018). Prussian blue nanozyme with multienzyme activity reduces colitis in mice. ACS Appl Mater Interfaces 10, 26108–26117.
Zhao, J., Gao, W., Cai, X., Xu, J., Zou, D., Li, Z., Hu, B., and Zheng, Y. (2019). Nanozyme-mediated catalytic nanotherapy for inflammatory bowel disease. Theranostics 9, 2843–2855.
Zhao, S., Li, Y., Liu, Q., Li, S., Cheng, Y., Cheng, C., Sun, Z., Du, Y., Butch, C.J., and Wei, H. (2020). An orally administered CeO2@Montmorillonite nanozyme targets inflammation for inflammatory bowel disease therapy. Adv Funct Mater 30, 2004692.
Acknowledgements
This work was supported by the National Key Research and Development Program of China (2019YFA0709200), Natural Science Foundation of Jiangsu Province (BK20180340), the National Natural Science Foundation of China (21722503, 21874067), CAS Interdisciplinary Innovation Team (JCTD-2020-08), PAPD program, the Innovation Foundation of Nanjing University, and Fundamental Research Funds for the Central Universities (021314380145).
Author information
Authors and Affiliations
Corresponding author
Additional information
Compliance and ethics
The author(s) declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Cheng, C., Zhao, S., Cheng, Y. et al. Design of nanozymes for inflammatory bowel disease therapy. Sci. China Life Sci. 64, 1368–1371 (2021). https://doi.org/10.1007/s11427-020-1937-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-020-1937-6